About: The use of convalescent plasma therapy and remdesivir in the successful management of a critically ill obstetric patient with novel coronavirus 2019 infection: A case report

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: The use of convalescent plasma therapy and remdesivir in the successful management of a critically ill obstetric patient with novel coronavirus 2019 infection: A case report Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	The use of convalescent plasma therapy and remdesivir in the successful management of a critically ill obstetric patient with novel coronavirus 2019 infection: A case report
Creator	Anderson, Jonathon Bryant, Suzanne Schauer, Jordan Edu, Jordan Schauer,
Source	Elsevier; Medline; PMC
abstract	Remdesivir is a novel therapeutic with known activity against SARS CoV-2 and related coronaviruses. Remdesivir, as well as convalescent plasma therapy, are currently under investigation as potential therapies for patients with Coronavirus Disease 19 (COVID-19). In this case report we summarize the use of convalescent plasma therapy and then remdesivir as a late addition in the treatment of a critically ill obstetric patient with COVID-19. The patient subsequently improved, was extubated 5 days after initiation of remdesivir, was transitioned to room air 24 h later, and discharged at the completion of remdesivir therapy.
has issue date	2020-05-16(xsd:dateTime)
bibo:doi	10.1016/j.crwh.2020.e00221
bibo:pmid	32426243
has license	no-cc
sha1sum (hex)	c83ae93e413a0da481b74ff2a465adb1db1fb255
schema:url	https://doi.org/10.1016/j.crwh.2020.e00221
resource representing a document's title	The use of convalescent plasma therapy and remdesivir in the successful management of a critically ill obstetric patient with novel coronavirus 2019 infection: A case report
has PubMed Central identifier	PMC7229947
has PubMed identifier	32426243
schema:publication	Case Rep Womens Health
resource representing a document's body	covid:c83ae93e413a0da481b74ff2a465adb1db1fb255#body_text
is schema:about of	named entity 'therapeutic' named entity 'patient' named entity 'discharged' named entity 'Coronavirus' named entity 'management' named entity '2019' named entity 'plasma' named entity 'RELATED' named entity 'ROOM AIR' named entity 'OBSTETRIC PATIENT' named entity 'CONVALESCENT PLASMA THERAPY' named entity 'CASE REPORT' named entity 'completion' named entity 'Remdesivir' named entity 'therapy' named entity 'critically ill' named entity 'convalescent plasma therapy' named entity 'SARS CoV' named entity 'case report' named entity 'infection' named entity 'convalescent plasma therapy' named entity 'convalescent plasma therapy' named entity 'case report' named entity 'infection' named entity 'remdesivir' named entity 'mechanical ventilation' named entity 'remdesivir' named entity 'remdesivir' named entity 'Remdesivir' named entity 'virus' named entity 'remdesivir' named entity 'Medical therapy' named entity 'fetal' named entity 'SARS' named entity 'inflammatory reaction' named entity 'COVID-19' named entity 'Remdesivir' named entity 'COVID' named entity 'antenatal care' named entity 'oxygen therapy' named entity 'remdesivir' named entity 'AST' named entity 'nasal cannula' named entity 'critically ill' named entity 'Chest x-ray' named entity 'MERS' named entity 'remdesivir' named entity 'mouse models' named entity 'medical history' named entity 'extubation' named entity 'maternal fetal medicine' named entity 'mechanical ventilation' named entity 'Baricitinib' named entity 'RNA-dependent RNA polymerase' named entity 'respiratory distress' named entity 'severe acute respiratory syndrome coronavirus 2' named entity 'remdesivir' named entity 'convalescent plasma' named entity 'shortness of breath' named entity 'corticosteroids' named entity 'remdesivir' named entity 'nucleoside analog' named entity 'convalescent plasma therapy' named entity 'cardiac arrhythmia' named entity 'chief complaint' named entity 'United States' named entity 'transaminitis' named entity 'infection' named entity 'hydroxychloroquine' named entity 'chief complaint' named entity 'coronavirus infections' named entity 'steroids' named entity 'virus' named entity 'lopinavir/ritonavir' named entity 'SARS-CoV-2' named entity 'Ribavirin' named entity 'compassionate-use'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software